These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2977984)

  • 21. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
    Rosales OR; Sander GE; Roffidal L; Given MB; Giles TD
    Chest; 1989 Jan; 95(1):43-7. PubMed ID: 2521204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of left ventricular hypertrophy by antihypertensive therapy.
    Reichek N; Franklin BB; Chandler T; Muhammad A; Plappert T; St John Sutton M
    Eur Heart J; 1982 Apr; 3 Suppl A():165-9. PubMed ID: 6210542
    [No Abstract]   [Full Text] [Related]  

  • 23. Regression of left ventricular mass in systemic hypertension.
    Georgiou D; Brundage BH
    Clin Cardiol; 1992 Jan; 15(1):5-16. PubMed ID: 1531790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possibilities of reverse development of left-ventricular hypertrophy in hypertension].
    Bakhshaliev AB; Akhmetzianova EKh; Gadzhiev RF; Teboeva RV
    Klin Med (Mosk); 1989 Mar; 67(3):10-7. PubMed ID: 2526273
    [No Abstract]   [Full Text] [Related]  

  • 25. Regression of structural alterations in hypertension.
    Agabiti-Rosei E; Muiesan ML; Muiesan G
    Am J Hypertens; 1989 Feb; 2(2 Pt 2):70S-76S. PubMed ID: 2522006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regression of left-ventricular myocardial hypertrophy in patients with hypertension during long-term treatment with beta-adrenergic blockaders].
    Shkhvatsabaia IK; Iurenev AP; Charyev KhE
    Kardiologiia; 1986 Mar; 26(3):28-33. PubMed ID: 2872357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian blood pressure pattern in patients with treated hypertension and left ventricular hypertrophy.
    Klein W; Zweiker R; Eber B; Dusleag J; Brussee H; Rotman B
    Angiology; 1991 May; 42(5):379-86. PubMed ID: 1827968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
    Messerli FH; Soria F
    Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regression of left ventricular hypertrophy in hypertensive patients under long-term therapy with antihypertensive agents].
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    Dtsch Med Wochenschr; 1990 Apr; 115(16):603-9. PubMed ID: 2139409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The regression of left ventricular hypertrophy following a short antihypertensive treatment].
    Soria F; Alegría E; Valdés M; García A; Vicente T; Apellaniz G
    Rev Esp Cardiol; 1991; 44(6):389-94. PubMed ID: 1833800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic regression of cardiac hypertrophy in experimental hypertension.
    Pfeffer MA; Pfeffer JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S865-9. PubMed ID: 6084141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of coronary insufficiency during prolonged treatment of essential hypertension.
    Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV
    Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac hypertrophy and aortic distensibility in essential hypertension.
    Safar ME; Laurent S; Asmar RA; Hugue CJ; London GM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S86-90. PubMed ID: 2485034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antihypertensive agent cicletanine reverses vascular hyperreactivity to noradrenaline and cardiac hypertrophy in DOCA-salt rats.
    Castro A; Parra L; Alsasua A; Fuentes JA
    Arch Int Pharmacodyn Ther; 1990; 307():109-18. PubMed ID: 2151359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive drug therapy and regression of left ventricular hypertrophy: a review with a focus on diuretics.
    Moser M; Setaro JF
    Eur Heart J; 1991 Sep; 12(9):1034-9. PubMed ID: 1834464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrocardiographic evolution of severe medically treated hypertension].
    Blancher JF; Ben-Mais H; Simon A; Aboras N; Kheder A; Safar M
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):296-300. PubMed ID: 158350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias and changes in blood pressure and left ventricular mass induced by antihypertensive treatment in hypertensive patients.
    Malerba M; Muiesan ML; Zulli R; Rizzoni D; Calebich S; Agabiti-Rosei E
    J Hypertens Suppl; 1991 Dec; 9(6):S162-3. PubMed ID: 1840186
    [No Abstract]   [Full Text] [Related]  

  • 40. Regression of left ventricular hypertrophy from systemic hypertension by gallopamil.
    Franz IW; Behr U; Ketelhut R; Agrawal B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S178-81. PubMed ID: 2455127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.